| Cat. No. |
Product Name |
Information |
| PC-60694 |
LX2931
S1P lyase inhibitor
|
LX-2931 (LX2931) is a potent, selective and orally bioavailable S1P lyase (S1PL) inhibitor. |
| PC-60693 |
S1P Lyase inhibitor 31
S1PL inhibitor
|
S1P Lyase inhibitor 31 is a potent, selective and orally bioavailable S1P lyase (S1PL) inhibitor with enzyme IC50 of 44 nM, cell IC50 of 110 nM. |
| PC-60680 |
ES936
NQO1 inhibitor
|
ES936 is a potent, specific mechanism-based human NAD(P)H: quinone oxidoreductase 1 (NQO1) inhibitor that demonstrates efficient inactivation of NQO1 at 100 nM in in cellular systems. |
| PC-60677 |
AR03
APE1 inhibitor
|
AR03 (BMH-23, AR03, Ape1 repair inhibitor 03) is a novel small molecule inhibitor of DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) endonuclease activity with IC50 of 5 uM. |
| PC-60661 |
PD 404182
DDAH1 inhibitor
|
PD 404182 (PD404182, PD-404182) is a heterocyclic iminobenzothiazine derivative with antimicrobial and anti-inflammatory properties, a potent inhibitor of human DDAH1 activity (IC50=9 uM) and elevates cellular ADMA levels. |
| PC-60650 |
Ru360
MCU inhibitor
|
Ru360 is a cell-permeable mitochondrial calcium uptake (MCU) inhibitor that binds to mitochondria with high affinity (Kd=340 pM) and blocks Ca2+ uptake into mitochondria in vitro with IC50 of 184 pM. |
| PC-60649 |
AG311
Necrosis inducer
|
AG311 is a first-in-class antitumor and antimetastatic agent that induces necrosis in breast cancer tumors, inhibits inhibit mitochondria complex I activity and reduces HIF-1α stabilization. |
| PC-60634 |
APX3330
APE1 inhibitor
|
APX3330 (E3330) is a specific small-molecule inhibitor of Apurinic/apyrimidinic endonuclease 1 (APE1) redox function (IC50=50 uM), but not APE1 DNA repair activity. |
| PC-60633 |
APX2009
Ref-1/APE1 inhibitor
|
APX2009 (APX-2009) is a novel potent inhibitor of reduction-oxidation factor 1-apurinic/apyrimidinic endonuclease 1 (Ref-1/APE1) with IC50 of 0.45 uM for redox EMSA inhibition. |
| PC-60631 |
OX03050
Squalene synthase inhibitor
|
OX03050 is a potent, competitive squalene synthase inhibitor that upregulate the LDLR in mouse and human liver cell lines with EC50 of 26 nM. |
| PC-60594 |
Dihydromunduletone
GPR56 INHIBITOR
|
Dihydromunduletone is a rotenoid derivative that selectively inhibits GPR56 (IC50=21 uM) and GPR114/ADGRG5, but not GPR110 or Class A GPCRs. |
| PC-60560 |
LQB-118
|
LQB-118 is an orally active pterocarpanquinone that exhibits antitumoral and antileishmanial activity both in vitro and in vivo. |
